CKD Patients Not on Dialysis
Hemodialysis – Drug Dosing in Hemodialysis
- Vancomycin Predialysis Concentrations
- Aminoglycoside Protocol 3x per week HD
- Cefazolin Short DailyHD Modeling (update in progress)
- Meropenem 3x per week HD Modelling (update in progress)
- Dialyze-IHD Website
Clinical Tools
- Medication Card (pdf) (Word Document – right click to save)
- Oseltamivir (Tamiflu) Renal Dosing Recommendations
- Management of Severe Hypersensitivity Reactions to Intravenous Iron
- Oral Potassium Chloride and Citrate Products
- Stepwise Approach to Uremic Pruritus
- Hydroxyzine (Atarax®) and Risk of QT Interval Prolongation and Torsades de Pointes
- Non-Dialysis CKD (CKD-ND) and Peritoneal Dialysis (PD) Iron Management Protocol for Patients with Iron Deficiency or receiving Erythropoietic Stimulating Agent (ESA)
- Patient Instructions for LMWH Bridging
- Hemodialysis Anticoagulation Record (warfarin) W-00838.
Peritoneal Dialysis
Other Useful Links
Disclaimer: The information and data in this document (“Information”) is based on scientific evidence current as of the date issued and is subject to change without notice. The Information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Any person consulting or applying the Information is expected to use independent medical judgment and expertise in the context of individual clinical circumstances. Winnipeg Regional Health Authority and the Manitoba Renal Program make no representation or guarantees of any kind whatsoever regarding the content or use or application of the Information and specifically disclaim any responsibility for its application or use in any way.
